Comparison of the renal response of bortezomib-based induction and conventional regimen in multiple myeloma patients with renal failure. Ann Med Res . 2021;28(10):1824-1829. Accessed May 9, 2025. http://www.annalsmedres.org/index.php/aomr/article/view/3934